Publikasi Scopus 2024 per tanggal 31 Mei 2024 (409 artikel)

Priyatini T.; Surya R.; Djusad S.; Santoso B.I.
Priyatini, Tyas (57192265423); Surya, Raymond (56986345100); Djusad, Suskhan (57192276788); Santoso, Budi Iman (56653822500)
57192265423; 56986345100; 57192276788; 56653822500
Is Vaginal Laser Promising for Stress Urinary Incontinence Treatment? A Systematic Review
2024
Journal of South Asian Federation of Obstetrics and Gynaecology
16
2
121
125
4
0
Department of Obstetrics and Gynecology, Faculty of MedicinDr, Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia
Priyatini T., Department of Obstetrics and Gynecology, Faculty of MedicinDr, Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Surya R., Department of Obstetrics and Gynecology, Faculty of MedicinDr, Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Djusad S., Department of Obstetrics and Gynecology, Faculty of MedicinDr, Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Santoso B.I., Department of Obstetrics and Gynecology, Faculty of MedicinDr, Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia
Introduction: The treatment for stress urinary incontinence (SUI) includes conservative and surgical management. Apart from advantages and disadvantages, vaginal laser is considered as an alternative therapy for SUI. This study aims to review the effectiveness of laser therapy either erbium-doped yttrium–aluminum–garnet (Er:YAG) or carbon dioxide (CO2) laser for female SUI. Methods: We used preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines for the appraisal. Eligibility criteria was SUI women undergoing Er:YAG or CO2 lasers compared with conservative or surgical management concerning the outcome such as improvement of SUI severity, sexual function, and quality of life. Results: Three studies consisting of one randomized controlled trial (RCT) and two prospective studies were included and assessed for risk of bias using the revised Cochrane risk-of-bias tool (RoB 2) and the risk of bias in nonrandomized studies – of interventions (ROBINS-I) assessment tool. All studies showed improvement of SUI in Er:YAG laser therapy, subjectively; however, they were still inconsistent objectively. Meanwhile, based on data on sexual function, both lasers showed little improvement and were not statistically significant (p = 0.066). Conclusion: Current evidence shows Er:YAG laser has a superior effect to sham laser in SUI patients subjectively. On the contrary, there is only a little evidence comparing Er:YAG laser with both conservative and surgical management of SUI. © The Author(s). 2024 Open Access.
CO2 laser; Er:YAG laser; Sexual function; Stress urinary incontinence
carbon dioxide; erbium; clinical outcome; disease severity; Female Sexual Function Index; human; laser therapy; muscle contraction; Pelvic Organ Prolapse Urinary Incontinence Sexual Questionnaire-12; physiological stress; quality control; quality of life; randomized controlled trial (topic); Review; risk assessment; sexual function; stress incontinence; systematic review; urine incontinence; vaginal laser
Jaypee Brothers Medical Publishers (P) Ltd
09748938
Review
#N/A
#N/A
#N/A